rs3828322 |
chr2 |
160807597 |
0.000125 |
A |
T |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs6432570 |
chr2 |
160808314 |
0.000874 |
T |
C |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs12692578 |
chr2 |
160829503 |
0.0000445 |
T |
C |
Cognitive impairment induced by topiramate |
PLA2R1 |
intron |
22091778
|
rs3828324 |
chr2 |
160834991 |
0.000746 |
T |
C |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs3828324 |
chr2 |
160834991 |
0.000224 |
T |
C |
Smoking initiation |
PLA2R1 |
intron |
24665060
|
rs979129 |
chr2 |
160840151 |
0.000253 |
T |
A,C,G |
Smoking initiation |
PLA2R1 |
intron |
24665060
|
rs12692579 |
chr2 |
160841139 |
0.000402 |
G |
A |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs1546512 |
chr2 |
160841307 |
0.0000174 |
C |
T |
Intelligence |
PLA2R1 |
intron |
21826061
|
rs6757188 |
chr2 |
160843623 |
0.000301 |
T |
C |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs3792167 |
chr2 |
160845582 |
0.000762 |
G |
C |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs3792168 |
chr2 |
160846472 |
0.000493 |
T |
C |
Smoking initiation |
PLA2R1 |
intron |
24665060
|
rs1397712 |
chr2 |
160866165 |
0.0000548 |
C |
A |
Type 2 diabetes |
PLA2R1 |
intron |
17463246
|
rs2667011 |
chr2 |
160867059 |
0.0000000000000334 |
G |
A |
Bilirubin levels,in serum |
PLA2R1 |
intron |
20639394
|
rs2667012 |
chr2 |
160867553 |
0.000234 |
C |
A |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs2666997 |
chr2 |
160876151 |
0.000833 |
G |
A |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs17830558 |
chr2 |
160878364 |
0.00048 |
T |
G |
Breast cancer (survival) |
PLA2R1 |
intron |
22232737
|
rs3792185 |
chr2 |
160878783 |
0.000596 |
T |
G |
Multiple complex diseases |
PLA2R1 |
intron |
17554300
|
rs3749117 |
chr2 |
160885442 |
0.0001 |
T |
C |
Information processing speed |
PLA2R1 |
missense |
21130836
|
rs3749117 |
chr2 |
160885442 |
0.000017 |
T |
C |
Waist-Hip Ratio |
PLA2R1 |
missense |
pha003029
|
rs3792189 |
chr2 |
160885872 |
0.0000717 |
C |
A |
Serum metabolites |
PLA2R1 |
intron |
19043545
|
rs3792189 |
chr2 |
160885872 |
0.0000715 |
C |
A |
Waist-Hip Ratio |
PLA2R1 |
intron |
pha003029
|
rs3792192 |
chr2 |
160886875 |
0.0000947 |
G |
A |
Information processing speed |
PLA2R1 |
intron |
21130836
|
rs3792192 |
chr2 |
160886875 |
0.0000359 |
G |
A |
Waist-Hip Ratio |
PLA2R1 |
intron |
pha003029
|
rs17241282 |
chr2 |
160891009 |
0.0000897 |
T |
C |
Information processing speed |
PLA2R1 |
intron |
21130836
|
rs6722275 |
chr2 |
160893260 |
0.0000185 |
C |
T |
Waist-Hip Ratio |
PLA2R1 |
intron |
pha003029
|
rs10929965 |
chr2 |
160906931 |
0.000947 |
A |
G |
Type 2 diabetes |
PLA2R1 |
intron |
17463246
|
rs2715928 |
chr2 |
160913599 |
0.000879 |
A |
G |
Response to statin treatment (atorvastatin),change in cholesterol levels |
PLA2R1 |
intron |
20031582
|
rs2667033 |
chr2 |
160913693 |
0.000148 |
A |
G |
Stroke |
PLA2R1 |
intron |
pha002887
|
rs16844715 |
chr2 |
160915106 |
0.000426 |
C |
T |
Type 2 diabetes |
PLA2R1 |
intron |
17463246
|
rs4664308 |
chr2 |
160917497 |
9e-29 |
A |
G |
Nephropathy (idiopathic membranous) |
PLA2R1 |
intron |
21323541
|